Akebia Therapeutics Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio2.591.200.361.871.37
P/B Ratio-8.43-7.6420.305.341.63
Price/Tangible Book8.36
Enterprise Value Ratios
EV/Revenue3.021.550.411.710.82
EV/EBITDA39.44
Profitability & Returns
Return on Equity (ROE)-2.38%-1.75%-1.20%
Return on Assets (ROA)-0.12%-0.09%-0.05%-0.24%-0.15%
Return on Capital Employed (ROCE)-0.33%-0.31%-0.15%-0.85%-0.38%
Leverage & Solvency Ratios
Debt/Equity-3.84-4.7230.072.560.51
Debt/EBITDA18.82
Liquidity Ratios
Current Ratio1.411.181.431.041.99
Quick Ratio1.070.821.010.791.59
Efficiency Ratios
Asset Turnover0.690.650.660.360.42
Inventory Turnover1.642.130.771.670.72
Yield & Distribution Ratios
Earnings Yield-0.17%-0.22%-0.89%-0.71%-0.95%
FCF Yield-0.10%-0.10%-0.69%-0.64%-0.27%
Buyback Yield-0.13%-0.03%-0.10%-0.20%-0.17%